MediXall Group, Inc. (MDXL)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Mar 5, 2026
MediXall Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 0.3 | 0.31 | 0.06 | 0.01 | - | 0 | Upgrade
|
| Revenue Growth (YoY) | 29.41% | 422.07% | 295.25% | - | - | 44.51% | Upgrade
|
| Cost of Revenue | 0.97 | 1.24 | 3.2 | 3.07 | 2.53 | 1.37 | Upgrade
|
| Gross Profit | -0.66 | -0.93 | -3.14 | -3.05 | -2.53 | -1.37 | Upgrade
|
| Selling, General & Admin | 1.3 | 2.98 | 3.36 | 3.33 | 2.78 | 2.05 | Upgrade
|
| Other Operating Expenses | - | - | -0.18 | -0.02 | 0.62 | - | Upgrade
|
| Operating Expenses | 1.3 | 2.98 | 3.18 | 3.31 | 3.4 | 2.05 | Upgrade
|
| Operating Income | -1.97 | -3.92 | -6.32 | -6.37 | -5.93 | -3.42 | Upgrade
|
| Interest Expense | -0.81 | -0.65 | -0.27 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -2.77 | -4.56 | -6.59 | -6.37 | -5.93 | -3.42 | Upgrade
|
| Asset Writedown | - | - | -0.24 | - | - | - | Upgrade
|
| Other Unusual Items | 0.61 | - | - | 0.17 | - | - | Upgrade
|
| Pretax Income | -2.16 | -4.56 | -6.83 | -6.2 | -5.93 | -3.42 | Upgrade
|
| Net Income | -2.16 | -4.56 | -6.83 | -6.2 | -5.93 | -3.42 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.27 | 0.31 | 0.31 | 0.25 | 0.04 | - | Upgrade
|
| Net Income to Common | -2.43 | -4.88 | -7.14 | -6.45 | -5.97 | -3.42 | Upgrade
|
| Shares Outstanding (Basic) | 141 | 127 | 117 | 104 | 91 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 141 | 127 | 117 | 104 | 91 | 74 | Upgrade
|
| Shares Change (YoY) | 13.83% | 9.00% | 11.96% | 14.98% | 22.25% | 14.03% | Upgrade
|
| EPS (Basic) | -0.02 | -0.04 | -0.06 | -0.06 | -0.07 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.04 | -0.06 | -0.06 | -0.07 | -0.05 | Upgrade
|
| Free Cash Flow | -1.2 | -1.23 | -3.56 | -4.69 | -4.14 | -2.35 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.04 | -0.05 | -0.03 | Upgrade
|
| Operating Margin | -645.91% | -1265.64% | -10665.08% | -42456.11% | - | -127409.72% | Upgrade
|
| Profit Margin | -798.78% | -1576.10% | -12053.42% | -43014.33% | - | -127409.72% | Upgrade
|
| Free Cash Flow Margin | -395.05% | -397.37% | -6010.77% | -31251.15% | - | -87617.95% | Upgrade
|
| EBITDA | -1.94 | -3.88 | -6.29 | -6.36 | -5.93 | -3.42 | Upgrade
|
| D&A For EBITDA | 0.03 | 0.03 | 0.04 | 0 | 0 | 0 | Upgrade
|
| EBIT | -1.97 | -3.92 | -6.32 | -6.37 | -5.93 | -3.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.